Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Hinge Health (HNGE) EPS (Weighted Average and Diluted) (2024 - 2026)

Hinge Health's EPS (Weighted Average and Diluted) history spans 2 years, with the latest figure at $2.11 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 4.98% to $2.11 in Q4 2025 year-over-year; TTM through Dec 2025 was -$9.0, a 955.57% decrease, with the full-year FY2025 number at -$7.77, down 782.95% from a year prior.
  • EPS (Weighted Average and Diluted) hit $2.11 in Q4 2025 for Hinge Health, up from -$0.02 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for HNGE hit a ceiling of $2.11 in Q4 2025 and a floor of -$13.1 in Q2 2025.